When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Post-chemotherapy cognitive impairment - Wikipedia

   en.wikipedia.org/wiki/Post-chemotherapy...

   The systems of the body most affected by chemotherapy drugs include visual and semantic memory, attention and motor coordination and executive functioning. [9] [10] These effects can impair a chemotherapy patient's ability to understand and make decisions regarding treatment, perform in school or employment and can reduce quality of life. [10]

3. CHOP (chemotherapy) - Wikipedia

   en.wikipedia.org/wiki/CHOP_(chemotherapy)

   This regimen can also be combined with the monoclonal antibody rituximab if the lymphoma is of B cell origin; this combination is called R-CHOP. In 2002, a randomized controlled trial showed a higher complete response rate for R-CHOP vs CHOP in elderly patients with Diffuse Large-B-Cell Lymphoma (76% vs 63%). [ 4 ]

4. ABVD - Wikipedia

   en.wikipedia.org/wiki/ABVD

   Side effects of ABVD can be divided into acute (those occurring while receiving chemotherapy) and delayed (those occurring months to years after completion of chemotherapy). Delayed side effects have assumed particular importance because many patients treated for Hodgkin lymphoma are cured and can expect long lives after completion of chemotherapy.

5. Lymphoma - Wikipedia

   en.wikipedia.org/wiki/Lymphoma

   The treatment of side effects is also important as they can occur due to the chemotherapy or the stem cell transplantation. It was evaluated whether mesenchymal stromal cells can be used for the treatment and prophylaxis of graft-versus-host diseases. The evidence is very uncertain about the therapeutic effect of mesenchymal stromal cells to ...

6. Loncastuximab tesirine - Wikipedia

   en.wikipedia.org/wiki/Loncastuximab_tesirine

   Participants in the clinical trial were also evaluated for side effects for the purpose of this drug application. [4] Trials were conducted at 28 sites in the United States, the United Kingdom, Italy, and Switzerland. [4] Loncastuximab tesirine was granted orphan drug designation by the FDA for the treatment of diffuse large B-cell lymphoma.

7. Rituximab - Wikipedia

   en.wikipedia.org/wiki/Rituximab

   Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...